Ignite Creation Date:
2025-12-26 @ 5:23 PM
Ignite Modification Date:
2026-03-10 @ 10:18 AM
Study NCT ID:
NCT04507906
Status:
COMPLETED
Last Update Posted:
2022-06-28
First Post:
2020-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC
Sponsor:
Shanghai Chest Hospital
Organization: